CPTx
PrivateLast Round
Grant
Aug 14, 2025
Total Funding Raised
$30.16M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
CPTx is a biotechnology company that develops in vivo genetic medicines and antiviral solutions using an immune-silent single-stranded DNA (ssDNA) platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CPTx Comparables
Compare CPTx with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NanoCell Therapeutics | 87% | |
| Stylus Medicine | 84% | |
| AbbVie | 84% | |
CPTx Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Aug 14, 2025 | ||||
| Early Funding | Sep 12, 2024 |
Key People
Founding team and executive leadership
CPTx Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Eureka Network | Grant |
| BlueYard Capital | Early Funding |
| Bayern Kapital | Early Funding |
| European Union | Grant |
| SPRIND | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 22, 2026
Monthly visitors increased 160% MoM.
- Sep 3, 2025
David Maier appointed to lead gxstrands business unit.
CPTx Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about CPTx's valuation, stock price, and market status.